ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,487,242, issued on Dec. 2, was assigned to Prelude Corp. (Laguna Hills, Calif.).
"DCIS recurrence and invasive breast cancer" was invented by Troy M. Bremer (Irvine, Calif.) and Steven Paul Linke (Carlsbad, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology generally relates to methods and compositions relevant to the prediction that a subject with and/or after treatment for DCIS will experience a subsequent ipsilateral breast event that is a DCIS recurrence, an invasive breast cancer, both a DCIS recurrence and invasive cancer, or neither. The technology can assist one with how to treat such subjects."
The patent was filed on ...